Bessemer Group Inc Cytokinetics Inc Transaction History
Bessemer Group Inc
- $60.7 Billion
- Q3 2024
A detailed history of Bessemer Group Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Bessemer Group Inc holds 1,932 shares of CYTK stock, worth $81,491. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,932
Previous 1,216
58.88%
Holding current value
$81,491
Previous $66,000
54.55%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CYTK
# of Institutions
416Shares Held
127MCall Options Held
4.46MPut Options Held
2.42M-
Black Rock Inc. New York, NY14.7MShares$619 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$503 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$409 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$333 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$272 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.97B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...